Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion and NRT for Smoking Cessation in Schizophrenia
NCT00320723Phase 4Completed
- Sponsor
- North Suffolk Community Services
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupropion in nicotine dependence (3 arms), sponsored by North Suffolk Community Services. Primary endpoints: Smoking Cessation Rate at 2 years and Smoking Reduction Rate at 2 years. Started Jul 2001; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00320723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320723.